ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2043

Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)

Isabel Castrejón1, Martin J. Bergman2 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Taylor Hospital, Ridley Park, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Assessment, gout, Osteoarthritis, patient questionnaires and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: The health assessment questionnaire (HAQ) and multidimensional HAQ (MDHAQ) were developed initially to assess patients with rheumatoid arthritis (RA). The most feasible method to ensure that each RA patient completes an MDHAQ at each visit is for the receptionist to present an MDHAQ to each patient with any diagnosis when registering for the visit, to complete in the waiting area. Data are then available for patients with all diagnoses, providing an opportunity to compare baseline scores and change over 2 months in patients with any rheumatic disease to patients with RA.

Methods: In the private practice of one rheumatologist, every patient with any diagnosis completes a 2-page MDHAQ at every visit before seeing the doctor. The MDHAQ includes 0-10 scores for physical function (MDHAQ-FN), pain and patient global estimate (PATGL), and a 0-30 score for routine assessment of patient index data (RAPID3), an index of the 3 patient self-report RA Core Data Set measures. Mean scores for individual measures and RAPID3 were compared at first visit and 2 months later for 141 new patients with 5 diagnoses: RA (n=39), osteoarthritis (OA) (n=41), systemic lupus erythematosus (SLE) (n=14), spondyloarthropathy (SpA) (n=23) and gout (n=24). Statistical significance was assessed by t test for change from baseline to 2 months later within each diagnostic group, and by analysis of variance (ANOVA) for change across diagnostic groups.

Results: Mean MDHAQ-FN scores at baseline ranged from 1.5 to 2.5, and from 1.1 to 1.9 two months later, documenting improvement of 9.4–26.8% in all diseases but OA (p <0.05 for all patients and RA). Mean pain scores at baseline ranged from 4.2 to 5.9, and from 3.0 to 4.7 two months later, documenting improvement of 20.2–35.3% in the 5 diagnoses (p <0.05 for all patients, RA, OA and gout). Mean PATGL at baseline ranged from 4.3 to 5.6, and from 3.3 to 5.0 two months later, documenting improvement of 11.2–30.4% (p £0.05 for all patients, RA, OA and gout). RAPID3 scores at baseline ranged from 10.1 to 13.7, and from 7.4 to 11.3 two months later, documenting improvement of 16.8–27.5% (p <0.05 for all patients, RA, OA and gout). No differences for mean change from baseline to 2 months between diagnostic groups were statistically significant.

Conclusion: Disease severity and improvement over 2 months according to MDHAQ-FN, pain, PATGL and RAPID3 scores were similar to RA in OA, SLE, SpA and gout. Physicians appropriately view these 5 diagnoses as distinct, based on differences in their pathophysiology and treatments, emphasizing the need for a knowledgeable physician to establish distinct, accurate diagnoses in individual patients. However, from the patients’ perspective, most rheumatic diseases are viewed more similarly than may be recognized by health professionals, documented by MDHAQ/RAPID3 scores.


Disclosure:

I. Castrejón,
None;

M. J. Bergman,
None;

T. Pincus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/documentation-of-improvement-over-2-months-in-osteoarthritis-systemic-lupus-erythematosus-spondyloarthropathy-and-gout-similarly-to-rheumatoid-arthritis-according-to-function-pain-patient-global-e/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology